Cargando…

Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system

Hyperpolarized contrast agents (HyCAs) have enabled unprecedented magnetic resonance imaging (MRI) of metabolism and pH in vivo. Producing HyCAs with currently available methods, however, is typically time and cost intensive. Here, we show virtually-continuous production of HyCAs using parahydrogen-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Andreas B., Zimmermann, Mirko, Berner, Stephan, de Maissin, Henri, Müller, Christoph A., Ivantaev, Vladislav, Hennig, Jürgen, Elverfeldt, Dominik v., Hövener, Jan-Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814607/
https://www.ncbi.nlm.nih.gov/pubmed/36697573
http://dx.doi.org/10.1038/s42004-022-00634-2
_version_ 1784864173132349440
author Schmidt, Andreas B.
Zimmermann, Mirko
Berner, Stephan
de Maissin, Henri
Müller, Christoph A.
Ivantaev, Vladislav
Hennig, Jürgen
Elverfeldt, Dominik v.
Hövener, Jan-Bernd
author_facet Schmidt, Andreas B.
Zimmermann, Mirko
Berner, Stephan
de Maissin, Henri
Müller, Christoph A.
Ivantaev, Vladislav
Hennig, Jürgen
Elverfeldt, Dominik v.
Hövener, Jan-Bernd
author_sort Schmidt, Andreas B.
collection PubMed
description Hyperpolarized contrast agents (HyCAs) have enabled unprecedented magnetic resonance imaging (MRI) of metabolism and pH in vivo. Producing HyCAs with currently available methods, however, is typically time and cost intensive. Here, we show virtually-continuous production of HyCAs using parahydrogen-induced polarization (PHIP), without stand-alone polarizer, but using a system integrated in an MRI instead. Polarization of ≈2% for [1-(13)C]succinate-d(2) or ≈19% for hydroxyethyl-[1-(13)C]propionate-d(3) was created every 15 s, for which fast, effective, and well-synchronized cycling of chemicals and reactions in conjunction with efficient spin-order transfer was key. We addressed these challenges using a dedicated, high-pressure, high-temperature reactor with integrated water-based heating and a setup operated via the MRI pulse program. As PHIP of several biologically relevant HyCAs has recently been described, this Rapid-PHIP technique promises fast preclinical studies, repeated administration or continuous infusion within a single lifetime of the agent, as well as a prolonged window for observation with signal averaging and dynamic monitoring of metabolic alterations.
format Online
Article
Text
id pubmed-9814607
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98146072023-01-10 Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system Schmidt, Andreas B. Zimmermann, Mirko Berner, Stephan de Maissin, Henri Müller, Christoph A. Ivantaev, Vladislav Hennig, Jürgen Elverfeldt, Dominik v. Hövener, Jan-Bernd Commun Chem Article Hyperpolarized contrast agents (HyCAs) have enabled unprecedented magnetic resonance imaging (MRI) of metabolism and pH in vivo. Producing HyCAs with currently available methods, however, is typically time and cost intensive. Here, we show virtually-continuous production of HyCAs using parahydrogen-induced polarization (PHIP), without stand-alone polarizer, but using a system integrated in an MRI instead. Polarization of ≈2% for [1-(13)C]succinate-d(2) or ≈19% for hydroxyethyl-[1-(13)C]propionate-d(3) was created every 15 s, for which fast, effective, and well-synchronized cycling of chemicals and reactions in conjunction with efficient spin-order transfer was key. We addressed these challenges using a dedicated, high-pressure, high-temperature reactor with integrated water-based heating and a setup operated via the MRI pulse program. As PHIP of several biologically relevant HyCAs has recently been described, this Rapid-PHIP technique promises fast preclinical studies, repeated administration or continuous infusion within a single lifetime of the agent, as well as a prolonged window for observation with signal averaging and dynamic monitoring of metabolic alterations. Nature Publishing Group UK 2022-02-18 /pmc/articles/PMC9814607/ /pubmed/36697573 http://dx.doi.org/10.1038/s42004-022-00634-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Schmidt, Andreas B.
Zimmermann, Mirko
Berner, Stephan
de Maissin, Henri
Müller, Christoph A.
Ivantaev, Vladislav
Hennig, Jürgen
Elverfeldt, Dominik v.
Hövener, Jan-Bernd
Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title_full Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title_fullStr Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title_full_unstemmed Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title_short Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
title_sort quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an mri system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814607/
https://www.ncbi.nlm.nih.gov/pubmed/36697573
http://dx.doi.org/10.1038/s42004-022-00634-2
work_keys_str_mv AT schmidtandreasb quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT zimmermannmirko quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT bernerstephan quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT demaissinhenri quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT mullerchristopha quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT ivantaevvladislav quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT hennigjurgen quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT elverfeldtdominikv quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem
AT hovenerjanbernd quasicontinuousproductionofhighlyhyperpolarizedcarbon13contrastagentsevery15secondswithinanmrisystem